Nuclear medicine technology is a branch of medical imaging that uses small amounts of radioactive materials to see how your organs and tissues are functioning, not just what they look like. Unlike an X-ray or CT scan that captures a picture of your body’s structure, nuclear medicine reveals activity at the cellular level: how blood flows through your heart, which areas of your brain are most active, or whether cancer cells are rapidly consuming energy. The same technology can also deliver targeted radiation to treat certain diseases.
How Nuclear Medicine Works
The process starts with a radioactive tracer, sometimes called a radiopharmaceutical. This is a molecule made of two parts: a carrier molecule designed to interact with a specific process in your body, and a radioactive atom attached to it. Once injected (or sometimes swallowed or inhaled), the tracer travels through your body and collects in the organ or tissue being studied.
What makes this clever is how specific the targeting can be. Cancer cells, for example, burn through sugar far faster than normal cells. A tracer built around a sugar-like molecule will concentrate heavily in tumors, lighting them up on a scan. In some cases, doctors can even use your own cells as carriers. If they need to find the source of intestinal bleeding, they may draw a sample of your red blood cells, attach radioactive atoms to them, and re-inject them so the cells naturally travel to the bleeding site.
As the tracer decays, it emits tiny bursts of energy that specialized cameras detect from outside your body. The scanner collects those signals and builds a detailed image of what’s happening inside, showing function and metabolism rather than anatomy alone.
PET and SPECT: The Two Main Scan Types
Most nuclear medicine imaging falls into two categories. PET (positron emission tomography) scanners detect pairs of photons released when the tracer decays, producing highly detailed 3D maps of metabolic activity. PET is widely used in oncology to find tumors, assess whether cancer has spread, and monitor how well treatment is working.
SPECT (single-photon emission computed tomography) scanners work on a similar principle but detect single photons and are especially common for heart and brain imaging. A SPECT scan can reveal how completely your heart chambers empty during contractions, identify areas of the heart muscle that aren’t getting enough blood, or create a blood-flow map of the brain to help pinpoint the source of seizures in epilepsy. SPECT is also used to detect hidden bone fractures that don’t show up on standard X-rays, track cancer that has spread to bones, and help confirm a diagnosis of Parkinson’s disease through a specialized dopamine transporter scan.
Nuclear Medicine vs. Traditional Imaging
Standard radiology (X-rays, CT, MRI, ultrasound) excels at showing structure. It can reveal a broken bone, a herniated disc, or a mass in the lung. But it often can’t tell you whether that mass is actively growing or whether the heart muscle downstream from a narrowed artery is still alive. Nuclear medicine fills that gap by showing metabolic activity and organ function. In practice, the two are often combined. A PET/CT scan, for instance, overlays a metabolic image on top of a structural one, giving doctors both the “what” and the “how” in a single session.
How Nuclear Medicine Treats Disease
Nuclear medicine isn’t only diagnostic. The same principle of targeted delivery can be used therapeutically. Instead of attaching a low-energy atom that’s good for imaging, scientists attach a higher-energy atom that can destroy nearby cells. The most established example is radioactive iodine therapy for thyroid cancer. Because thyroid cells naturally absorb iodine, a radioactive form of iodine concentrates in thyroid tissue and delivers a lethal dose of radiation directly to cancer cells while largely sparing the rest of the body.
Newer targeted treatments use a radioactive form of lutetium. One version treats neuroendocrine tumors by binding to receptors on the tumor surface. Another targets a protein found on prostate cancer cells. These therapies are part of a growing field called theranostics, which pairs a diagnostic imaging agent with a therapeutic agent that targets the same molecule. Doctors first scan to confirm the tumor expresses the right target, then treat with a therapy designed to hit that exact target. It’s one of the most active areas of cancer research, with new agents in development for several tumor types.
Radiation Exposure in Context
Any procedure involving radioactive materials raises a reasonable question about safety. The doses used in nuclear medicine are low and carefully controlled. A PET scan delivers roughly 7 mSv (millisieverts) of radiation, comparable to a CT scan of the chest (about 6 mSv) and well below a coronary angiogram with interventions (around 15 mSv). A nuclear bone scan comes in at about 6.3 mSv. For comparison, a standard two-view chest X-ray delivers just 0.1 mSv, and average background radiation from natural sources gives you about 3 mSv per year just from living on Earth.
The guiding principle for all radiation use in medicine is ALARA, which stands for “as low as reasonably achievable.” In practice, this means three things: minimizing the time spent near a radioactive source, maximizing distance from it, and using shielding when possible. That’s why the technologist steps behind a barrier when operating equipment. The tracer dose itself is calculated to be just enough to produce a clear image, nothing more. Most tracers decay quickly and are cleared from the body within hours to days.
What a Nuclear Medicine Technologist Does
The professionals who perform these procedures are nuclear medicine technologists. Their daily work includes explaining the procedure to patients, preparing and administering the radioactive tracer, operating the imaging equipment, following strict radiation safety protocols, and maintaining detailed records of each procedure and how radioactive materials are handled and disposed of.
Becoming a nuclear medicine technologist typically requires completing an accredited program in nuclear medicine technology, which can be a two-year or four-year degree. Most technologists then pursue certification, which, while not always legally required, fulfills most state licensing requirements and is expected by many employers. The Nuclear Medicine Technology Certification Board (NMTCB) and the American Registry of Radiologic Technologists (ARRT) both offer credentialing exams. Beyond general certification, technologists can earn specialty credentials in PET imaging, nuclear cardiology, or CT. Many positions also require basic life support or CPR certification.
Common Conditions Evaluated With Nuclear Medicine
The range of conditions that nuclear medicine can assess is broad, spanning nearly every organ system:
- Cancer: PET scans detect tumors, determine whether cancer has spread, and track treatment response by measuring metabolic activity.
- Heart disease: Stress tests using radioactive tracers reveal areas of the heart that aren’t receiving adequate blood flow, helping diagnose coronary artery disease and assess damage after a heart attack.
- Neurological conditions: Brain SPECT and PET scans map blood flow and activity patterns to help diagnose dementia, locate the origin of seizures, evaluate head trauma, and support Parkinson’s disease diagnosis.
- Bone disorders: Nuclear bone scans detect fractures that are too subtle for X-rays, identify bone infections, and locate sites where cancer has spread to the skeleton.
- Thyroid disease: Radioactive iodine uptake tests evaluate thyroid function, and higher-dose iodine therapy treats hyperthyroidism and thyroid cancer.
- Kidney and lung function: Specialized scans measure how well each kidney filters blood or assess blood flow in the lungs to check for clots.
Because nuclear medicine captures function rather than structure, it often detects disease earlier than conventional imaging. A tumor may be metabolically active and visible on a PET scan before it grows large enough to show up on a CT. Similarly, reduced blood flow to part of the heart can appear on a nuclear stress test before any structural damage is visible. This ability to catch problems at a cellular and molecular level is what makes nuclear medicine a distinct and increasingly important part of modern diagnostics and treatment.